CCG-203971

CAS: 1443437-74-8

Ref. TM-T4306

Produktinformation

• Name: CCG-203971
• Synonyme: CCG203971
• CAS: 1443437-74-8

Beschreibung

CCG-203971 is an inhibitor of SRE activation in the prostate cancer cell line PC-3 (IC50: 6.4 μM), with 87% inhibition of SRE activation achieved at 100 μM. This compound also inhibits PC-3 cell migration (IC50: 4.2 μM), as determined by a scratch wound assay. CCG-203971(CCG203971) causes no cytotoxicity when evaluated by the WST-1 assay. It is well tolerated in normal mice up to doses of 100 mg/kg given intraperitoneally over five days.

• Marke: Targetmol

Chemische Eigenschaften

• Molekulargewicht: 408.88
• Formel: C₂₃H₂₁ClN₂O₃
• Reinheit: 99.35%
• Farbe/Form: Solid